Élisa Demonchy
Impact in
-
- Antibiotic Use and Resistance
- Infectious Diseases top 10%
- COVID-19 Clinical Research Studies
- SARS-CoV-2 and COVID-19 Research
Papers in
-
- COVID-19 Clinical Research Studies 6
- SARS-CoV-2 and COVID-19 Research 5
- Antimicrobial Resistance in Staphylococcus 5
- HIV/AIDS drug development and treatment 4
- Epidemiology 15
- Infective Endocarditis Diagnosis and Management 6
- Co-authors
- Karine Risso (10 shared papers)Johan Courjon (13 shared papers)Éric Cua (5 shared papers)Céline Pulcini (3 shared papers)Pierre‐Marie Roger (5 shared papers)J. Levraut (2 shared papers)Jean-Charles Dufour (1 shared paper)P.-M. Roger (4 shared papers)
- Journals
- European Journal of Clinical Microbiology & Infectious Diseases (7 papers)Journal of Antimicrobial Chemotherapy (5 papers)Clinical Infectious Diseases (3 papers)Frontiers in Medicine (3 papers)Infection (3 papers)
- Partner nations
- FranceMartiniqueUnited Kingdom
In The Last Decade
Élisa Demonchy
58 papers receiving 777 citations
Peers
Comparison fields: 5 of 91
- Applied Microbiology and Biotechnology 62
- Infectious Diseases 252
- Sensory Systems 44
- Virology 35
- Neurology 87
Countries citing papers authored by Élisa Demonchy
This map shows the geographic impact of Élisa Demonchy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Élisa Demonchy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Élisa Demonchy more than expected).
Fields of papers citing papers by Élisa Demonchy
This network shows the impact of papers produced by Élisa Demonchy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Élisa Demonchy. The network helps show where Élisa Demonchy may publish in the future.
Co-authors
The 25 scholars most cited alongside Élisa Demonchy, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 62 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 71 | |
| 2 | 2014 | 61 | |
| 3 | 2021 | 60 | |
| 4 | 2017 | 36 | |
| 5 | 2023 | 36 | |
| 6 | 2021 | 35 | |
| 7 | 2017 | 33 | |
| 8 | 2011 | 28 | |
| 9 | 2015 | 25 | |
| 10 | 2022 | 23 | |
| 11 | 2023 | 23 | |
| 12 | 2017 | 21 | |
| 13 | 2017 | 20 | |
| 14 | 2021 | 18 | |
| 15 | 2018 | 17 | |
| 16 | 2020 | 17 | |
| 17 | 2017 | 16 | |
| 18 | 2022 | 16 | |
| 19 | 2021 | 14 | |
| 20 | 2021 | 13 |
About Élisa Demonchy
Élisa Demonchy is a scholar working on Infectious Diseases, Epidemiology, Applied Microbiology and Biotechnology, Sensory Systems and Neurology, having authored 62 papers that have together received 800 indexed citations. Recurring topics across this work include COVID-19 Clinical Research Studies (6 papers), Infective Endocarditis Diagnosis and Management (6 papers), Long-Term Effects of COVID-19 (5 papers), SARS-CoV-2 and COVID-19 Research (5 papers), Antimicrobial Resistance in Staphylococcus (5 papers), Olfactory and Sensory Function Studies (4 papers), HIV/AIDS drug development and treatment (4 papers) and Antibiotic Use and Resistance (4 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (62 citations), Infectious Diseases (252 citations), Sensory Systems (44 citations), Virology (35 citations) and Neurology (87 citations). Élisa Demonchy has collaborated with scholars based in France, Martinique and United Kingdom. Frequent co-authors include Karine Risso, Johan Courjon, Éric Cua, Céline Pulcini, Pierre‐Marie Roger, J. Levraut, Jean-Charles Dufour, P.-M. Roger, David Chirio and Jean Gaudart. Their work appears in journals such as European Journal of Clinical Microbiology & Infectious Diseases, Journal of Antimicrobial Chemotherapy, Clinical Infectious Diseases, Frontiers in Medicine and Infection.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.